Literature DB >> 8778030

Protein kinase C isotype expression and regulation of lymphoid cell motility.

K M Thorp1, H Verschueren, P De Baetselier, C Southern, N Matthews.   

Abstract

Lymphocyte migration into inflammatory sites involves a change from a spherical, non-motile phenotype to an irregular, constantly shape-changing, motile phenotype. We have previously shown that lymphocytes are maintained in the non-motile state by the constitutive activity of protein kinase C (PKC). In this paper we have attempted to identify the PKC isotype which regulates these morphological changes by three different approaches. (a) Motile and non-motile T-cell lines were compared for expression of the alpha, beta I, beta II, gamma, delta, epsilon, eta, zeta and theta isotypes by Western blotting. There was no obvious correlation of isotype expression with motility. (b) Two different PKC inhibitors, one specific for classical isotypes, Go6976 and the other GF109203X, which inhibits both classical and non-classical isotypes were compared for induction of motility in non-motile lymphocytes. Only GF109203X induced motility implying that a non-classical isotype is involved. (c) Non-motile lymphocytes were chronically treated with the PKC activator bryostatin and the time courses of induction of motility and downregulation of PKC isotypes were compared. Induction of motility correlated better with downregulation of epsilon, eta and theta than with alpha or beta. It is concluded that the data fit best with the involvement of a non-classical PKC isotype in regulating lymphocyte motility although no association with a particular isotype was found.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8778030      PMCID: PMC1384113          DOI: 10.1046/j.1365-2567.1996.486567.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Expression and partial characterization of rat protein kinase C-delta and protein kinase C-zeta in insect cells using recombinant baculovirus.

Authors:  E McGlynn; J Liebetanz; S Reutener; J Wood; N B Lydon; H Hofstetter; M Vanek; T Meyer; D Fabbro
Journal:  J Cell Biochem       Date:  1992-07       Impact factor: 4.429

Review 2.  Protein kinase C.

Authors:  S Stabel; P J Parker
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Inhibition of protein kinase C results in a switch from a non-motile to a motile phenotype in diverse human lymphocyte populations.

Authors:  C Southern; P C Wilkinson; K M Thorp; L K Henderson; M Nemec; N Matthews
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

Review 5.  Protein kinase C--a question of specificity.

Authors:  L V Dekker; P J Parker
Journal:  Trends Biochem Sci       Date:  1994-02       Impact factor: 13.807

Review 6.  Protein kinase C isoenzymes: divergence in signal transduction?

Authors:  H Hug; T F Sarre
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

7.  Heterogeneity of protein kinase C expression and regulation in T lymphocytes.

Authors:  S Lucas; R Marais; J D Graves; D Alexander; P Parker; D A Cantrell
Journal:  FEBS Lett       Date:  1990-01-15       Impact factor: 4.124

8.  Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976.

Authors:  G Martiny-Baron; M G Kazanietz; H Mischak; P M Blumberg; G Kochs; H Hug; D Marmé; C Schächtele
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

9.  Metastatic competence of BW5147 T-lymphoma cell lines is correlated with in vitro invasiveness, motility and F-actin content.

Authors:  H Verschueren; I Van der Taelen; J Dewit; J De Braekeleer; P De Baetselier
Journal:  J Leukoc Biol       Date:  1994-04       Impact factor: 4.962

10.  Selective responses (actin polymerization, shape changes, locomotion, pinocytosis) to the PKC inhibitor Ro 31-8220 suggest that PKC discriminately regulates functions of human blood lymphocytes.

Authors:  S Trachsel; H U Keller
Journal:  J Leukoc Biol       Date:  1995-04       Impact factor: 4.962

View more
  2 in total

1.  Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes.

Authors:  G Werlen; E Jacinto; Y Xia; M Karin
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

2.  PKCθ regulates T cell motility via ezrin-radixin-moesin localization to the uropod.

Authors:  Judy L Cannon; Francois Asperti-Boursin; Kenneth A Letendre; Ivy K Brown; Katy E Korzekwa; Kelly M Blaine; Sreenivasa R Oruganti; Anne I Sperling; Melanie E Moses
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.